Benjamin Nacev

Citado por

	Total	Desde 2020
Citas	2040	1387
Índice h	20	16
Índice i10	30	24

400

200

100

300

20072008200920102011201220132014201520162017201820192020202120222023202420259 9 7 5 29 38 48 72 61 70 81 85 109 133 205 293 308 392 52

Acceso público

Ver todo

30 artículos

0 artículos

disponibles

no disponibles

Basado en requisitos de financiación

Coautores

Jun O. LiuJohns Hopkins School of MedicineDirección de correo verificada de jhu.edu
Sandra P. D'AngeloMemorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
Li-Xuan QinMemorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
Tom W. MuirPrinceton UniversityDirección de correo verificada de princeton.edu
Shridhar BhatResearch Associate and NMR Manager, Pharmacology & Molecular Sciences, Johns HopkinsDirección de correo verificada de jhu.edu
Lijuan FengPostdocDirección de correo verificada de Rockefeller.edu
JD BagertAstraZenecaDirección de correo verificada de astrazeneca.com
Agata Lemiesz PatriotisThe Rockefeller UniversityDirección de correo verificada de rockefeller.edu
Joong Sup ShimAssociate Professor of Faculty of Health Sciences, University of MacauDirección de correo verificada de umac.mo
Alexey SoshnevAssistant professor, Neuroscience, Developmental and Regenerative Biology, UT San AntonioDirección de correo verificada de utsa.edu
Feiran ZhangNovo NordiskDirección de correo verificada de dicerna.com
Nikolaus SchultzCenter for Molecular Oncology, Memorial Sloan Kettering Cancer CenterDirección de correo verificada de cbio.mskcc.org
Ritika KundraMemorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
JianJiong GaoMemorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
Prof. Stuart M. HaslamImperial College LondonDirección de correo verificada de imperial.ac.uk
Jing XuUT Southwestern Medical CenterDirección de correo verificada de jhmi.edu
Blake T Aftab, PhDChief Scientific Officer @ Adicet BioDirección de correo verificada de aftab.com
Dehua PeiProfessor of Chemistry and Biochemistry, The Ohio State UniversityDirección de correo verificada de osu.edu
Charles RudinChief, Thoracic Oncology, Memorial Sloan Kettering Cancer CenterDirección de correo verificada de mskcc.org
William B. IsaacsProfessor of Urology and Oncology, Brady Urological Inst, Johns Hopkins Univ, School of MedicineDirección de correo verificada de jhmi.edu

Seguir

Benjamin Nacev

University of Pittsburgh School of Medicine

Dirección de correo verificada de upmc.edu - Página principal

Cancer epigenetics Sarcoma Chromatin Histones


Título Ordenar por citas Ordenar por año Ordenar por título	Citado por Citado por	Año
The expanding landscape of ‘oncohistone’mutations in human cancers BA Nacev, L Feng, JD Bagert, AE Lemiesz, JJ Gao, AA Soshnev, ... Nature 567 (7749), 473-478, 2019	360	2019
Protein N-Terminal Processing: Substrate Specificity of Escherichia coli and Human Methionine Aminopeptidases Q Xiao, F Zhang, BA Nacev, JO Liu, D Pei Biochemistry 49 (26), 5588-5599, 2010	217	2010
The epigenomics of sarcoma BA Nacev, KB Jones, AM Intlekofer, JSE Yu, CD Allis, WD Tap, M Ladanyi, ... Nature Reviews Cancer 20 (10), 608-623, 2020	191	2020
The antifungal drug itraconazole inhibits vascular endothelial growth factor receptor 2 (VEGFR2) glycosylation, trafficking, and signaling in endothelial cells BA Nacev, P Grassi, A Dell, SM Haslam, JO Liu Journal of Biological Chemistry 286 (51), 44045-44056, 2011	149	2011
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets BA Nacev, F Sanchez-Vega, SA Smith, CR Antonescu, E Rosenbaum, ... Nature Communications 13 (1), 3405, 2022	135	2022
Effect of nitroxoline on angiogenesis and growth of human bladder cancer JS Shim, Y Matsui, S Bhat, BA Nacev, J Xu, HC Bhang, S Dhara, KC Han, ... Journal of the National Cancer Institute 102 (24), 1855-1873, 2010	130	2010
Mechanisms of aneuploidy in thyroid cancer cell lines and tissues: evidence for mitotic checkpoint dysfunction without mutations in BUB1 and BUBR1 B Ouyang, JA Knauf, K Ain, B Nacev, JA Fagin Clinical endocrinology 56 (3), 341-350, 2002	80	2002
Simultaneous targeting of NPC1 and VDAC1 by itraconazole leads to synergistic inhibition of mTOR signaling and angiogenesis SA Head, WQ Shi, EJ Yang, BA Nacev, SY Hong, KK Pasunooti, RJ Li, ... ACS chemical biology 12 (1), 174-182, 2017	77	2017
Itraconazole side chain analogues: structure–activity relationship studies for inhibition of endothelial cell proliferation, vascular endothelial growth factor receptor 2 … W Shi, BA Nacev, BT Aftab, S Head, CM Rudin, JO Liu Journal of medicinal chemistry 54 (20), 7363-7374, 2011	75	2011
Oncohistone mutations enhance chromatin remodeling and alter cell fates JD Bagert, MM Mitchener, AL Patriotis, BE Dul, F Wojcik, BA Nacev, ... Nature chemical biology 17 (4), 403-411, 2021	74	2021
High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S) BAP Wilson, H Wang, BA Nacev, RC Mease, JO Liu, MG Pomper, ... Molecular cancer therapeutics 10 (5), 825-838, 2011	64	2011
Impact of absolute stereochemistry on the antiangiogenic and antifungal activities of itraconazole W Shi, BA Nacev, S Bhat, JO Liu ACS medicinal chemistry letters 1 (4), 155-159, 2010	55	2010
Synergistic inhibition of endothelial cell proliferation, tube formation, and sprouting by cyclosporin A and itraconazole BA Nacev, JO Liu PloS one 6 (9), e24793, 2011	41	2011
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma SP D’Angelo, AL Richards, AP Conley, HJ Woo, MA Dickson, M Gounder, ... Nature communications 13 (1), 3477, 2022	37	2022
A phase II study of epacadostat and pembrolizumab in patients with advanced sarcoma CM Kelly, LX Qin, KA Whiting, AL Richards, V Avutu, JE Chan, P Chi, ... Clinical Cancer Research 29 (11), 2043-2051, 2023	36*	2023
Clinical, genomic, and transcriptomic correlates of response to immune checkpoint blockade-based therapy in a cohort of patients with angiosarcoma treated at a single center E Rosenbaum, CR Antonescu, S Smith, M Bradic, D Kashani, ... Journal for immunotherapy of cancer 10 (4), 2022	36	2022
Clinical Outcome of Leiomyosarcomas With Somatic Alteration in Homologous Recombination Pathway Genes E Rosenbaum, P Jonsson, K Seier, LX Qin, P Chi, M Dickson, M Gounder, ... JCO precision oncology 4, 1350-1360, 2020	32	2020
A calcineurin-independent mechanism of angiogenesis inhibition by a nonimmunosuppressive cyclosporin A analog BA Nacev, WK Low, Z Huang, TT Su, Z Su, H Alkuraya, D Kasuga, W Sun, ... Journal of Pharmacology and Experimental Therapeutics 338 (2), 466-475, 2011	26	2011
Phase II trial of imatinib plus binimetinib in patients with treatment-naive advanced gastrointestinal stromal tumor P Chi, LX Qin, B Nguyen, CM Kelly, SP D'Angelo, MA Dickson, ... Journal of Clinical Oncology 40 (9), 997-1008, 2022	21	2022
Pyridinylquinazolines selectively inhibit human methionine aminopeptidase-1 in cells F Zhang, S Bhat, SB Gabelli, X Chen, MS Miller, BA Nacev, YL Cheng, ... Journal of medicinal chemistry 56 (10), 3996-4016, 2013	21	2013

El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.

Artículos 1–20

Citas por año

Citas duplicadas

Citas combinadas

Añadir coautoresCoautores

Seguir

Citado por

Coautores